Status:
COMPLETED
Effects of TEAS on POCD
Lead Sponsor:
RenJi Hospital
Conditions:
Post-operative Cognitive Dysfunction
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Patients undergoing elective orthopedics, urology, and general surgery will be included and randomly allocated to TEAS group or control group . After routine anesthesia induction and tracheal intubati...
Detailed Description
This study will enroll 110 patients who are older than 60 years old and will have elective orthopedics, urology, or general surgeries under general anesthesia. Patients will be randomly assigned to TE...
Eligibility Criteria
Inclusion
- ≧ 60 years old;
- communicate normally；
- ASA Physical Status 1-2;
- Patients will have elective orthopedics, urology or general surgeries under general anesthesia;
- With an estimated surgery time of more than 2h;
- Agree to participate the trial.
Exclusion
- Patients with brain diseases or history of brain diseases;
- Preoperative diagnosis of cognitive impairment by subtle mental state (MMSE) less than 24 points;
- Patients with history of neurological and psychological disorders including AD, stroke, and psychosis;
- Severe hearing or visual impairment, illiteracy;
- preoperative systolic blood pressure \>190mmHg, or diastolic blood pressure \>100mmHg;
- Disagree to participate in this research;
- Have used other medical electronic devices.
Key Trial Info
Start Date :
October 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 26 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04338555
Start Date
October 14 2021
End Date
October 26 2022
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, China, 200127